SP
-
Global generic drug markets will grow to US$221 billion by 2016
Driven by the need to control costs, the use of generic drugs has grown considerably in recent years, even in markets where traditionally they have not been favored.
SP | 23 May 2012
-
Phosphagenics signs agreement with Nippon Zoki
The companies have struck a material transfer agreement which enables Nippon Zoki to test and assess Phosphagenics’ patented TPM/diclofenac topical non-steroidal pain formulation for its suitability as a prescription item in the USA and Japanese markets.
SP | 03 May 2012
-
Refinements in inhaled drug delivery enhances growth prospects as global markets emerge
Survey finds evolving device technologies creating opportunities for drug developers, according to Greystone Research Associates.
SP | 10 April 2012
-
ICON acquires PriceSpective
The acquisition strengthens ICON’s expertise in value based pricing and market access.
SP | 05 April 2012
-
AB SCIEX launches workhorse mass spectrometer for routine quantitation, screening
This system from AB SCIEX was developed based on feedback from scientists and application experts in analytical science that led to intelligently re-engineering the company’s existing API 4000.
SP | 04 April 2012
-
Espicom predicts new novel approaches to the treatment of cancer will be launched by 2018
According to an Espicom report, Targeted Cancer D: The launch landscape to 2018,the global cancer market could be set for rapid growth in key sectors, driven by increasingly un-met clinical need and the introduction of new drugs which effectively target new pathways.
SP | 29 March 2012
-
Generic drug manufacturers forge alliances in face of tough economic climate
The generic drugs sector’s role as the provider of affordable drugs has widely benefitted public and private health payers keen to control costs. But in the current economic climate, downward pressure on prices is impacting the generic sector, with increases in acquisition and strategic partnering now firmly part of the competitive landscape.
SP | 28 February 2012
-
Agilent Technologies replaces signal-to-noise spec for triple quadrupole GC/MS
Agilent Technologies announced that it is replacing the signal-to-noise specification with a instrument detection limit specification for its 7000B triple quadrupole gas chromatography/mass spectrometry system.
SP | 16 February 2012
-
Porex expands chromatography, SPE media offerings
Porex has enhanced its comprehensive line of chromatography and SPE Media solutions with versatile, high-performance porous materials and filters designed to endure the most challenging chromatography applications.
SP | 31 January 2012
-
Agilent Technologies joins sponsors of GreenCentre Canada
Agilent Technologies has joined the sponsors of GreenCentre Canada, a national centre of excellence for commercializing green chemistry discoveries generated by academic researchers and industry.
SP | 30 January 2012
